Table: Modalis Therapeutics - 6-MTH group results

Modalis Therapeutics

05/08/2022 07:00

Aug 5 (Reuters)- 
             Modalis Therapeutics Corporation 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Jun 30, 2022        Jun 30, 2021     Dec 31, 2022 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              40 mln               1 mln                     
                                       (-99.7 pct)                  
  Operating       loss 868 mln        loss 477 mln                  
  Recurring       loss 780 mln        loss 464 mln                  
  Net             loss 775 mln           17 mln                     
                                       (-34.1 pct)                  
  EPS            loss 26.70 yen         0.62 yen                    
  EPS Diluted                           0.59 yen                    
  Ann Div                                  NIL              NIL     
  -Q2 div              NIL                 NIL                      
  -Q4 div                                  NIL              NIL     
  
  NOTE - Modalis Therapeutics Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4883.T